Skip to main content

Opportunities and challenges of global health diplomacy for prevention and control of noncommunicable diseases: a systematic review


Background and aim

The growing globalization has changed the goals and methods of diplomacy. Due to the challenges and complexities of dealing with noncommunicable diseases (NCDs) at the national and international levels, policy makers require global health diplomacy (GHD) to achieve the goals of prevention and control of NCDs. The purpose of this systematic review was to identify the challenges and opportunities in GHD for NCDs.


A systematic review of articles was conducted by searching MEDLINE via PubMed, Web of Science, Scopus, and Embase and by using Google and Google Scholar search engines. Additional articles were identified by reviewing reference lists and a number of special journals. The inclusion criteria include literature published in English from 2007 to 2020, and the exclusion criteria are literature published in any language other than English, absence of full text, dissertations, and duplicates. Overall, 32 articles met the requirements for inclusion in this review and were analyzed using content analysis in MAXQDA 10.


There are 32 published articles on GHD for NCDs. Identified challenges were classified into three levels: global (global health governance), national (Governance at the state level, health sector, and civil society), and industry. The progress on global health issues has created opportunities for the development of GHD for the prevention and control of NCDs. These opportunities were divided into three levels: international, national, and individual level.


Various challenges at the global level, national level, and industry led to less engagement of policymakers in GHD for prevention and control of NCDs and, as a consequence, a less coordinated approach to address prevention and control of NCDs worldwide. So, there is a need for more efforts of collective action and negotiation for tackling NCDs. Policymakers and managers of the health system should increase the advocacy, building a coalition with civil society, use negotiation and diplomacy to engage with other sectors and organizations, manage industry conflicts, and leverage foreign policy to promote health and welfare.

Peer Review reports


Noncommunicable diseases (NCDs) are a major cause of death and disability worldwide. In developing countries, the burden of NCDs is increasing rapidly and will have significant social, economic, and health consequences [1]. For instance there has been an increase in the burden of NCDs in countries of Sub-Saharan Africa during the last decades, pushed through growing prevalence of cardiovascular threat factors which includes unhealthy diets, decreased physical activity, hypertension, obesity, diabetes, dyslipidaemia, and air pollution [2, 3]. As another example, the rising trend of deaths and years of disabilitydue to NCDs adjusted over the last decades is an impressive hazard to Iran. According to the Global Burden of Disease study, the mortality rate from non-communicable diseases has steadily increased from 50% in 1990 to 82% in 2017 in Iran [4]. NCDs not only lead to premature death but also cause significant disability [5]. Due to the sharp increase in mortality rates due to NCDs over the past two decades, especially in developing countries, the World Health Organization (WHO) has declared NCDs a top health priority for every country [6]. Cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes are four major NCDs [7]. Primary prevention is the key to controlling the global epidemics of NCDs. The main goal is to avert and control these epidemics wherever possible, and surveillance is crucial to its success [8]. The increasing prevalence of NCDs, especially in recent decades, has raised concerns about the health systems around the world and those involved with health policy making. The United Nations (UN) and WHO are among the bodies that have developed programs to prevent and control NCDs worldwide and have been working to promote health in this area [9, 10]. Evidence of this is the holding of high level meetings and the development of guidelines that target NCDs.

WHO has identified several health priority areas in cooperation and consultation with its member states. Prevention and control of NCDs is one of these priority areas that have been placed on the global health agenda and health diplomacy [10]. Tackling NCDs requires intersectoral collaboration. The prioritization and emphasis on a global commitment to tackle NCDs has led to the development of effective strategies such as a multi-stakeholder structure to serve as a holistic platform that enables transparency and accountability in negotiating policy space for NCDs [11]. One instance of successful global health negotiation and diplomacy is the Port of Spain Declaration on NCDs, which was elevated to a global level and led to the 2011 High Level Meeting on the Prevention and Control of Non-communicable Diseases by the UN [11, 12]. Therefore, global health diplomacy (GHD) is crucial to ensuring political commitment and intersectoral collaboration to tackle NCDs on a global scale [12].

There is emerging evidence that global trade is associated with the rise of chronic diseases in many low and middle-income countries (LMICs) [13]. In the short or medium term,the liberalization of food trade in 15 developing countries including Chile, Guatemala, Guyana, Peru, Cameroon, Ghana, Kenya, Malawi, Morocco, Nigeria, Senegal, Tanzania, Uganda, China, and India Reform can cause damage to food safety, if it’s far brought without a coverage package deal designed to offset the negative consequences of liberalization [14,15,16]. In addition, supporting evidence from India, the Pacific Islands, and Colombia shows that the growth of international trade has shifted the diet from a healthy local diet to a high-fat diet [17]. This is in part due to the global prevalence of unhealthy lifestyles and health-damaging products and is particularly challenging for countries that are vulnerable to the burdens of communicable diseases. To reduce the burden of NCDs, it is essential for health policy makers to use negotiation and diplomacy to interact with trade policy makers regarding the health effects of international trade agreements and ensure the flow of health-promoting products. Prevention and treatment of chronic diseases are currently on global policy agendas, as highlighted in the 2011 UN Summit on NCDs. There is a need for a more coordinated approach to regulating trade-related risk factors and increasing engagement between health and trade policy sectors within and between nations [13].

Overall, it can be concluded that the discussion of NCDs is not limited to one country or region and is a problem that all countries around the world are struggling with. Reducing the impact of NCDs on individuals and communities requires a comprehensive approach such as GHD that engages all sectors, including health, finance, foreign affairs, education, agriculture, planning and others to reduce the risks associated with NCDs and promote disease prevention and control interventions. Otherwise, it will be impossible to achieve the objectives set by WHO for the prevention and control of NCDs.

The UN Political Declaration was an important step in recognition of NCDs as a global health challenge in the twenty-first century that has undermined social and economic development and has threatened the achievement of development goals. On the other hand, the link between NCDs and Sustainable Development Goals (SDGs) as well as the unfinished agenda of Millennium Development Goals is another reason for the placement of NCDs on the global agenda and the emphasis on controlling them with collaboration and appropriate policies at the national and international levels [18].

The Political Declaration highlights strengthening health systems towards the provision of equitable, universal health coverage and promoting affordable access to prevention, treatment, care and support related to NCDs, especially cancer, cardiovascular diseases, chronic respiratory diseases, and diabetes, as one of the main challenges to sustainable development in the twenty-first century. It also commits to establishing or strengthening national and international multisectoral policies for the prevention and control of NCDs [9]. NCDs are a threat to the UN Millennium Development Goals and post-2015 development plans. Using high-impact, essential interventions such as GHD for NCDs to prevent and control these diseases is an excellent economic investment because they can reduce the need for more expensive treatments if provided early to patients.

One of the challenges in tackling NCDs is the complexity of these diseases as they have a wide range of risk factors from global (e.g., multinational fast food companies) to local (unwalkable streets) levels. In addition, not all chronic diseases can be prevented. Due to these complexities, it is difficult to specify the goals and required funds for the prevention and control of NCDs. The global response to these diseases must focus on generating multisectoral evidence regarding the transnational factors that contribute to the rise in NCDs as well as the potential policies proposed for controlling them [19]. Development and adoption of a global reaction to the upward push of chronic diseases in industrialized and developing countries calls for policy makers to engage in GHD. Successful developments in GHD depend on the performance of and respectful relationships among the stakeholders, and global health diplomats must have a deep understanding of the institutional structures and the ways in which these relationships work [12, 20]. The purpose of this systematic review is to identify the challenges and opportunities in GHD for NCDs.


The present research was a systematic review of the literature for identiffing opportunities and challenges of global health diplomacy (GHD) for the prevention and control of noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, respiratory diseases and cancer as well as their risk factors, including tobacco use, excessive salt and fat intake, alcohol abuse, and physical inactivity. This review covered the period 2007–2020.

The PICO framework (patient/population/participant problem, intervention, comparison, outcome) will be applied to the formulation of questions and will facilitate the clarification of search strategies. The PICO frameworkof this study have been given in supplementary file 1. Relevant articles were identified by searching MEDLINE database via PubMed, Web of Science, Scopus, and Embase along with Google and Google Scholar search engines. The keywords used in searches included English MeSH and common terms related to the topic, including “Diplomacy” OR “Internationality” OR “foreign policy” OR “foreign affairs” OR “international relations” OR “international politics” OR “statesmanship” OR “statecraft” OR “Health Diplomacy” OR “Medical Diplomacy” OR “Negotiations” OR “Multilateral Engagement” OR “Bilateral Agreements” and “Drinking Behavior” OR “Alcoholic Beverages” OR “Smoking” OR “Smokers” OR “Feeding Behavior” OR “Diet” OR “Obesity” OR “Food” OR “Fast Foods” OR “Sugars” OR “Sodium, Dietary” OR “Exercise” OR “Life Style” OR “Healthy Lifestyle” OR “Sedentary Behavior” OR “Alcohol Drinking” OR “Tobacco Use” OR “Tobacco Products” OR “Tobacco” OR “Noncommunicable Diseases” OR “Non-communicable Diseases”. The reference lists of identified articles were also manually searched to find more relevant papers.

Research studies, commentary, and review articles are all included in the qualitative synthesis. Because early searches of the literature revealed that the majority of relevant research were undertaken after 2007, the inclusion criteria for this study comprised literatures published in English and studies published between 2007 and 2020. The criterion for exclusion were publishing in any language other than English, absence of full text availability, dissertations, and duplicates.

There have been a total of 2045 items extracted. Based on the inclusion and exclusion criteria, the titles and abstracts of the papers were reviewed, leaving 54 articles for full-text review. 20 articles were eliminated because they were unavailable or duplicates and one article was excluded due to a non-English language (Russian) [21]. Finally, 32 papers were chosen for review. As a PRISMA Flow Diagram, Fig. 1 depicts the database search and article selection process [22].

Fig. 1

PRISMA Flow Diagram: Database search and article selection process

32 articles have been entered into the quality assessment stage. Quality become assessed independently with the aid of using research the use of the 15-point instrument of Mitton et al. [23]. Criteria for quality assessment included: literature review and identity of studies gaps; research questions, hypotheses, and design; population and sampling; data collection process and instruments; and analysis and reporting of results and every object is given a rating of 0 (not present or reported), 1 (present but low quality), 2 (present and midrange quality), or 3 (present and high quality). Disagreements have been resolved via way of means of discussion and, while essential, by consulting a third evaluation author. Given that the review was qualitative, articles have been not eliminated at this stage, however greater weight was given to articles with a quality score of 10 or above in the data analysis and interpretation of results.

In the next stage, a qualitative content analysis of the articles was performed. The obtained information was coded and analyzed using MAXQDA 10 software for Windows (VERBI GmbH, Berlin, Germany), and the themes and subthemes related to each article were extracted to identify their relationships, patterns, and core meanings. McQueen’s analytical framework for intersectoral governance [24] was used to explain the challenges of global health diplomacy for non-communicable diseases. Opportunities were also classified into three levels: international, national, and individual.


Between 2007 and 2020, a total of 32 articles have been published on GHD for NCDs. Identified challenges were classified at three levels, including global (global health governance), national (governance at the state level, health sector, and civil society), and industry. McQueen’s analytical framework for intersectoral governance was used to describe the challenges of GHD for NCDs at the global health governance and governance at the state level. This framework consists of governance structures that countries adopt in order to guide multisectoral actions. Identified actions include evidence support, coordination, advocacy, financial support, legal mandates, implementation, monitoring, and evaluation. Tables 1, 2 and 3 present the challenges of GHD for NCDs at different levels along with the identified solutions.

Table 1 Challenges of GHD for NCDs at the international level
Table 2 Challenges of GHD for NCDs at the national level
Table 3 Challenges of GHD for NCDs at the level of industries

The ability of governments to develop an effective health and fiscal policy aimed at improving lifestyle factors and preventing NCDs is directly linked to their negotiating capacity and their ability to build a national consensus [25]. The progress on global health has created opportunities for developing GHD for the prevention and control of NCDs. Table 4 provides the opportunities identified from the reviewed literature, which are classified at international, national, and individual levels. One of the most important opportunities at the international level is the support of international organizations such as the UN and WHO of prioritization of NCDs. Also, the great progress of global diplomacy in the Tobacco Control Framework Convention demonstrate the ability of the international community to advance the goals of NCD diplomacy. At the national level, one of these opportunities is the existence of cost-effective measures for NCD control and prevention.

Table 4 Opportunities created through GHD toward NCD prevention and control


Today’s world is more complex and interconnected than ever before. This requires countries to understand their interdependence and common interests. Without a deep understanding of this issue, governments will not be able to interact properly at the international level. There is also a need for collaboration based on a non-zero-​sum game or win-win strategy. Governments should align their national interests with regional and global interests and work to achieve them through collaboration [26,27,28]. Diplomacy, especially global health diplomacy (GHD), will be crucial in this regard. Given the complexity and challenging nature of addressing NCDs at the national and international level, this systematic review was conducted to identify the challenges and opportunities in GHD for NCDs. Between 2007 and 2020, 32 articles have been published concerning the challenges and opportunities in GHD for NCDs. It should be noted that, the analysis of this article uses specific information in the reviewed articles and may not be able to gather all the complex discussions which are written in the gray literatures.

The identified challenges were classified into three levels: global (global health governance), national (governance at the state level, health sector, and civil society), and industry. At the international level, insufficient scientific research [29], lack of technical expertise, insufficient information on developing and least developed countries, and potential differences between national and global priorities are some of the challenges that many countries face. For example, In India, solving the problem of childhood obesity is considered a kind of luxury. This creates a possible inconsistency between national and global priorities. This is reflected in the fact that for most Indian, more calories are preferable to fewer calories, which is the opposite of one set of recommendations [30] .

At the international level, there is power asymmetry in international negotiations. This is exacerbated in the context of GHD for NCDs, as health ministries and agencies are often less powerful within their own governments. Coalition building and preparation for negotiations are two strategies that have been proposed to overcome these challenges [12]. Moreover, GHD is more difficult for issues in which there is less interdependence among countries than issues such as NCDs in which countries are directly affected by the actions or inaction of their neighbors [13]. There are also complex and synergistic policies and political relations at both national and international levels [31]. As the Caribbean Community (CARICOM) has done to put NCDs on the UN agenda, or the European Union has done recently in response to the COVID19 pandemic, regional groups can play a key role in promoting global health by changing political relations and integrating advocacy efforts [32].

At the national level, the prioritization and implementation of interventions to maximize their impact is complex and requires effective partnerships both within the health sector (e.g., hospitals, clinics, and ministries/departments of health) and beyond the health sector (e.g., civil society, academia, media, and the private sector) [33]. For instance, community-Based Cardiovascular Disease Prevention Project in Finland (North Karelia Project) successfully used a multi-sectoral approach to reduce the risk factors associated with cardiovascular disease. This comprehensive intervention included health education and community empowerment, improving health care delivery, prevention efforts in several settings (schools, workplaces), media participation, with greater involvement of civil society and the private sector. Public health policies also played an important role in promoting low-fat options by regulating food labeling, tobacco regulations, and changing agricultural subsidies [34]. In addition to reducing risk factors, these multisectoral collaborations involve a large number of stakeholders at various levels, play a role in the development of multilateral and informal diplomacy, and change attitudes and influence the country’s public policy.

There is also a lack of awareness across sectors regarding their potential contribution. Ineffective health systems and poor economies in LMICs have made it difficult to address NCDs. Many countries lack the necessary technical expertise, resources, research capacity, and data to overcome the challenges posed by NCDs [35]. Scarcity of resources and competing infectious disease priorities in LMICs have complicated efforts to prevent and control NCD in these countries. Moreover, sanctions, including financial, travel and trade restrictions, are important barriers to these interactions [33, 36].

National investments are often low, and sufficient funds are not mobilized at the international level. Usually, a large number of policies are developed without the necessary structure and resources for implementation [36]. Resource gaps in many countries can be addressed through innovative funding mechanisms and more effective use of existing resources. Many NCD interventions are profitable, including alcohol and tobacco taxes that simultaneously reduce NCD risk and help reduce inequalities [36]. One of the challenges in tackling NCDs is the complexity of these diseases as they have a wide range of risk factors from global to local levels. In addition, not all NCDs are preventable. Due to these complexities, it is difficult to specify the goals and required funds for the prevention and control of NCDs. The global response to these diseases must focus on generating multisectoral evidence on the transnational factors that contribute to the rise in NCDs and the policies proposed for controlling them [19].

Another problem facing health systems is that 50 % of the world’s health ministries lack an NCD unit, especially in LMICs, and in those ministries that have an NCD unit, the staff often lack the necessary competencies [33]. Weak health systems, inadequate access, lack of prevention and health promotion services, and lack of evidence-based interventions and medicines are other challenges that hinder NCD prevention and control [35]. ALSO, Many developing countries have different major organizational structures with functions related to non-communicable diseases. Cambodia and the Philippines, Mongolia for example, have an independent national health promotion center. Many countries, including Malaysia, Mongolia, and the Philippines, have established health promotion committees to provide population-based primary prevention services for noncommunicable diseases. However, the relationship of these newly proposed structures to the existing organizational structures for health promotion or NCDs units in the Ministry of Health is not clearly defined. High potential overlap has been reported in the functions and responsibilities of these structures [37]. If the common goals stated in specific NCDs policies and programs are to be pursued effectively and efficiently, clarify the roles and responsibilities of each institutional structure involved to coordinate non-communicable disease functions, activities and resources across multiple organizational structures; Distinctive needs throughout the Ministry of Health.

On the other hand, power asymmetry and the fact that health ministries and agencies are often less powerful within their governments reduces the impact of political and diplomatic efforts, especially in intersectoral diplomacy. In some countries, the presence of national multisectoral governance and coordination structures or a mechanism to oversee NCD policy engagement beyond the health sector has facilitated multisectoral action in NCD policy development [38]; therefore, an effective solution for addressing this challenge is to develop multisectoral governance structures to tackle NCDs and their risk factors. To engage in the discourse of GHD, NGO diplomats face two immediate challenges: to convey the interests of the general public while contributing to inter-state negotiations in a system of governance that is state-centered and under pressure from private interests or the self-interest of government organizations [39]. According to Bond, one of the main goals of GHD is to “ensure dialogue with affected communities and be more intentional in engaging citizens and groups in defining needs and goals” [40].

Another major challenge is that there are diverse social movements with no clear organizational leader [19]. Moreover, national and international member societies are dominated by medical professionals and do not significantly involve people [12]. Civil society and NGOs are a key part of GHD for NCD prevention and control, and their strong presence on the global stage is indicative of their significance [41]. Another key factor in GHD is the presence of advocacy groups and activists in the area of NCDs. One of the most important lessons drawn from previous successes in GHD is that mobilization of civil society is key to ensuring a strong collective response. This has been recognized as a central element in FCTC negotiations [42]. The rise of the large coalition of NCD Alliance (NCDA) can help prioritize NCDs at every level of health diplomacy. Health diplomacy means building consensus and collaboration between governments and NGOs that operate at the community level and have the greatest access to people in need [43].

At the industry level, one of the most important challenges is the conflict of interest of various industries on health and NCD risk factors, including tobacco and alcohol industries. Conflict of interest can hinder or halt policy development and engagement of various sectors. One of the negative impacts of conflicting interests is the industry interference in the development and implementation of policies. Specifically, the interference of the tobacco industry with the policy process has been evident in almost all LMICs [44]. Multinational tobacco companies will continue to increase tobacco use in LMICs. However, there has been a lack of emphasis on NCD control by various sectors at national and global levels on issues such as government and NGO funding for research and prevention as well as development of coordinated strategies and diplomatic initiatives to address the multinational dimensions of the problem [19].

Countries must adopt a strong advocacy and communications strategy on multisectoral action for NCD prevention to raise awareness of NCDs in different sectors and address issues of conflict. They must implement strategies for addressing industry interference that hinders NCD prevention measures [36].

Recent efforts by the UN, WHO, and world authorities have created opportunities for tackling NCDs. One example of these efforts is WHO guidelines and recommendations. These recommendations are non-binding, but represent the official policy of this organization and define certain norms and standards [29]. Human rights approaches, equity-based approaches (non-discrimination, gender equality, participation), multisectoral and multi-stakeholder action, health-in-all-policies, whole-of-government and whole-of-society approaches, appropriate management of conflicts of interest, national action supported by international cooperation and solidarity, life-course approach, empowerment of individuals and communities, evidence-based strategies, and universal health coverage (UHC) are some of these recommendations. Access to affordable, cost-effective, and feasible interventions against NCDs support other health and development priorities [42].

GHD includes new forms of collective action and negotiation on new rules and norms for tackling global health challenges. The development of national policies and FCTC negotiations have clearly interacted. Thailand, Brazil, and the European Union followed Canada in adopting large graphic health warnings [44]. Until recently, GHD for NCDs was primarily WHO-centric. The UN High Level Meeting was an excellent opportunity for accomplishing the challenging task of elevating NCDs beyond the traditional health forum. An important consideration in decisions to engage in GHD on a given issue is the impact of the media on the political agenda. The media plays a more prominent role in putting issues on the foreign policy agenda than the domestic policy agenda [45].


Today, health has become an integral part of foreign policy and global agendas on security, global economy, and social justice. Reinforcing health as a social value and a human right, supporting the United Nations millennium development goals, advocating for access to medicines and primary health care, and calling for high income countries to invest in a broad range of global health initiatives are some of the key elements of these agendas [46]. Therefore, advocacy, building coalition with civil society, use of negotiation and diplomacy by health policy makers to engage with trade policy makers regarding the health impacts of international trade agreements, and management of industry conflicts are crucial for prevention and control of NCDs. There is a need for a more coordinated approach at the international level and a greater involvement by health systems and policy makers worldwide. On the other hand, developing a strategic document for public diplomacy, promoting national and transnational capacity building and cooperation, laying the groundwork for expansion of private-sector activities, and leveraging foreign policy to promote national health and welfare can play a key role in the prevention and control of NCDs at the national level. It is also necessary to build a national consensus, align interests with the country’s diplomacy, and monitor the global arena to take advantage of potential opportunities. Also, the use of training and research tools for translating foreign policy into action for NCD prevention and control can pave the way for reducing the burden of these diseases.

Availability of data and materials

Data relevant to the study are included in the article or uploaded as Additional files. The datasets used and analysed (include template data collection forms; data extracted from) available from the corresponding author on reasonable request.



Noncommunicable diseases


Global health diplomacy


United Nations


World Health Organization


Low and middle-income countries


Non-governmental organizations


Asia-Pacific Economic Cooperation


Pan American Health Organization


The Caribbean Community


Framework Convention on Tobacco Control


Noncommunicable diseases alliance


Sustainable development goals


  1. 1.

    Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health. 2005;4(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Glob Health. 2019;7(10):e1295–6.

    Article  PubMed  Google Scholar 

  3. 3.

    Gouda HN, Charlson F, Sorsdahl K, Ahmadzada S, Ferrari AJ, Erskine H, et al. Burden of non-communicable diseases in sub-Saharan Africa, 1990–2017: results from the global burden of disease study 2017. Lancet Glob Health. 2019;7(10):e1375–87.

    Article  PubMed  Google Scholar 

  4. 4.

    Sheidaei A, Gohari K, Kasaeian A, Rezaei N, Mansouri A, Khosravi A, et al. National and subnational patterns of cause of death in Iran 1990–2015: applied methods. Arch Iran Med. 2017;20(1):1–11.

    Google Scholar 

  5. 5.

    Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    WHO. Noncommunicable Diseases (NCD) Country Profiles. 2014.

    Google Scholar 

  7. 7.

    WHO Key facts. Noncommunicable diseases. 2018.

    Google Scholar 

  8. 8.

    Organization WH. STEPS: a framework for surveillance. The WHO STEPwise approach to surveillance of noncommunicable diseases (STEPS). Ginebra: OMS; 2003.

    Google Scholar 

  9. 9.

    Labonté R, Mohindra KS, Lencucha R. Framing international trade and chronic disease. Glob Health. 2011;7(1):21.

    Article  Google Scholar 

  10. 10.

    Kevany S. Global Health diplomacy, “San Francisco values,” and HIV/AIDS: from the local to the global. Ann Glob Health. 2015;81(5):611–7.

    Article  PubMed  Google Scholar 

  11. 11.

    Thaiprayoon S, Smith R. Capacity building for global health diplomacy: Thailand’s experience of trade and health. Health Policy Plan. 2014;30(9):1118–28.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Blouin C. Global responses to chronic diseases: what lessons can political science offer? Adm Sci. 2012;2(1):120–34.

    Article  Google Scholar 

  13. 13.

    Blouin C, Dubé L. Global health diplomacy for obesity prevention: lessons from tobacco control. J Public Health Policy. 2010;31(2):244–55.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Hawkes C, Thow A. Implications of the Central America-Dominican Republic-free trade agreement for the nutrition transition in Central America. Pan Am J Public Health. 2008;24(5):345–60.

    Article  Google Scholar 

  15. 15.

    Thow A, Hawkes C. The implications of trade liberalization for diet and health: a case study from Central America. Global Health. 2009;5:5.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Agriculture Organization of the United Nations. Animal Production, Health Division. Livestock Report 2006: Food & Agriculture Org; 2006.

  17. 17.

    Hawkes C, Chopra M, Friel S. In: Labonté R, Schrecker T, Packer C, Runnels V, editors. Globalization, trade, and the nutrition transition. Globalization and Health: Pathways, Evidence and Policy. New York: Routledge; 2009. p. 235–62.

    Google Scholar 

  18. 18.

    Alwan A. The World Health Assembly responds to the global challenge of noncommunicable diseases. East Mediterr Health J = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2013;19(6):511–2.

    Google Scholar 

  19. 19.

    Wipfli HL, Samet JM. Moving beyond global tobacco control to global disease control. Tob Control. 2012;21(2):269–72.

    Article  PubMed  Google Scholar 

  20. 20.

    Afshari M, Ahmadi Teymourlouy A, Asadi-Lari M, Maleki M. Global Health diplomacy for noncommunicable diseases prevention and control: a systematic review. Glob Health. 2020;16(1):1–6.

    Article  Google Scholar 

  21. 21.

    Maslennikova GY, Oganov RG. The Russian experience in reducing the burden of non-communicable diseases and suggestions for international cooperation. Profilakticheskaya Meditsina. 2016;19(4):4–6.

    Article  Google Scholar 

  22. 22.

    Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Mitton C, Adair CE, McKenzie E, Patten SB, Perry BW. Knowledge transfer and exchange: review and synthesis of the literature. Milbank Q. 2007;85(4):729–68.

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    McQueen DV, Wismar M, Lin V, Jones CM, Davies M, World Health Organization. Intersectoral governance for health in all policies: structures, actions and experiences: World Health Organization. Regional Office for Europe; 2012.

  25. 25.

    Adomako M, Kamiar A, Alshaikh A, Baines LS, Benson D, Bettcher DW, et al. The burgeoning role of global health diplomacy to alleviate suffering of cancer patients in low-and middle-income countries. Int Health. 2020;12(3):231–3.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Alaei K, Alaei A, Fox A. Strengthening US-Iranian relations through public health. Lancet Glob Health. 2015;3(9):e525–6.

    Article  PubMed  Google Scholar 

  27. 27.

    Divkolaye NSH, Radfar MH, Seighali F, Burkle FM. When health diplomacy serves foreign policy: use of soft power to quell conflict and crises. Disaster Med Public Health Prep. 2016;10(5):724–7.

    Article  Google Scholar 

  28. 28.

    Tabatabai A. Requirements for economic diplomacy. First Impression. 2009;3(20):80.

    Google Scholar 

  29. 29.

    Russell A, Wainwright M, Tilson M. Means and ENDS– e-cigarettes, the framework convention on tobacco control, and global health diplomacy in action. Glob Public Health. 2018;13(1):83–98.

    Article  PubMed  Google Scholar 

  30. 30.

    Smith R, Irwin R. Measuring success in global health diplomacy: lessons from marketing food to children in India. Glob Health. 2016;12(1):28.

    Article  Google Scholar 

  31. 31.

    Teixeira LA, Paiva CH, Ferreira VN. The World Health Organization framework convention on tobacco control in the Brazilian political agenda, 2003-2005. Cad Saude Publica. 2017;33(suppl 3).

  32. 32.

    Kickbusch I, Nikogosian H, Kazatchkine M, Kökény M. A guide to global health diplomacy: Graduate Institute of International and Development Studies, Global Health Centre; 2021.

  33. 33.

    Pearlman PC, Vinson C, Singh T, Stevens LM, Kostelecky B. Multi-stakeholder partnerships: breaking down barriers toeffective cancer-control planning and implementation in low-and middle-income countries. Sci Dipl. 2016;5:1–15.

    Google Scholar 

  34. 34.

    Puska P, Vartiainen E, Tuomilehto J, Nissinen A. 20-year experience with the North Karelia project. Preventive activities yield results. Nord Med. 1994;109(2):54–5.

    CAS  PubMed  Google Scholar 

  35. 35.

    Nishtar S, Niinistö S, Sirisena M, Vázquez T, Skvortsova V, Rubinstein A, et al. Time to deliver: report of the WHO Independent High-Level Commission on NCDs. Lancet (London, England). 2018;392(10143):245.

    Article  Google Scholar 

  36. 36.

    Juma PA, Mapa-Tassou C, Mohamed SF, Mwagomba BL, Ndinda C, Oluwasanu M, et al. Multi-sectoral action in non-communicable disease prevention policy development in five African countries. BMC Public Health. 2018;18(1):953.

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Rani M, Nusrat S, Hawken LH. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle-income countries: current status, risks and options. BMC Public Health. 2012;12(1):1–3.

    Article  Google Scholar 

  38. 38.

    Lencucha R, Kothari A, Labonté R. The role of non-governmental organizations in global health diplomacy: negotiating the framework convention on tobacco control. Health Policy Plan. 2010;26(5):405–12.

    Article  PubMed  Google Scholar 

  39. 39.

    Dain K. Challenges facing global health networks: the NCD Alliance experience: Comment on “Four challenges that global health networks face.”. Int J Health Policy Manag. 2018;7(3):282–5.

    Article  PubMed  Google Scholar 

  40. 40.

    Bond K. Health security or health diplomacy? Moving beyond semantic analysis to strengthen health systems and global cooperation. Health Policy Plan. 2008;23(6):376–8.

    Article  PubMed  Google Scholar 

  41. 41.

    Adams V, Novotny TE, Leslie H. Global health diplomacy. Med Anthropol. 2008;27(4):315–23.

    Article  PubMed  Google Scholar 

  42. 42.

    Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.

    Article  PubMed  Google Scholar 

  43. 43.

    Frist WH. Medicine as a currency for peace through global health diplomacy. Yale Law Policy Rev. 2007;26:209–29.

    Google Scholar 

  44. 44.

    Wood D, Peake J. The dynamics of foreign policy agenda setting. Am Polit Sci Rev. 1998;92(1):173–84.

    Article  Google Scholar 

  45. 45.

    Donnelly J. How did Sierra Leone provide free health care? Lancet. 2011;377(9775):1393–6.

    Article  PubMed  Google Scholar 

  46. 46.

    Kickbusch I. Global health diplomacy: how foreign policy can influence health. BMJ. 2011;342(jun10 1):d3154.

    Article  PubMed  Google Scholar 

Download references


Not applicable.


M Afshari conducted this study with research funding from Iran University of Medical Science (97–3–37-12777). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

Author information




MA, MAL and AAT designed the research;: MA, MAL and AAT conducted it; MA and AAT extracted the data; and: MA, MAL and AAT and MM wrote the paper. AAT had primary responsibility for final content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mahnaz Afshari.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Asadi-Lari, M., Ahmadi Teymourlouy, A., Maleki, M. et al. Opportunities and challenges of global health diplomacy for prevention and control of noncommunicable diseases: a systematic review. BMC Health Serv Res 21, 1193 (2021).

Download citation


  • Systematic review
  • Global health diplomacy
  • Noncommunicable diseases